OUR FOUNDERS

Syros’ scientific founders have produced groundbreaking discoveries in gene control.  

RICHARD YOUNG, PHD

Member, Whitehead Institute
Professor of Biology, Massachusetts Institute of Technology

World leader in regulatory circuitry that controls the gene expression programs in cells

 

JAY BRADNER, MD

President,  Novartis Institutes for BioMedical Research (NIBR) 
Attending Physician & Investigator, Department of Medical Oncology Dana-Farber Cancer Center
 

World leader in small-molecule modulation of gene regulatory pathways; pioneering work in the bromodomain area

 

NATHANAEL GRAY, PHD

Professor of Biological Chemistry & Molecular Pharmacology, Harvard Medical School | Dana-Farber Cancer Center

Pioneering use of synthetic chemistry and functional small molecule discovery to modulate biological pathways important in cancer; responsible for the discovery of numerous first-in-class kinase inhibitors


SCIENTIFIC ADVISORY BOARD

We have highly-engaged advisors who are leaders in gene control, cancer biology and drug development.

 

Richard Young, PhD*,  Whitehead Institute, Massachusetts Institute of Technology

Nathanael Gray, PhD*,  Harvard Medical School, Dana Farber Cancer Institute

Bradley Bernstein, MD, PhD,  Massachusetts General Hospital, Harvard Stem Cell Institute, Harvard Medical School, Howard Hughes Medical Institute, Broad Institute

Scott Biller, PhD,  Agios

Gerard Evan, PhD, FRS, FMedSci,  University of Cambridge, European Molecular Biology, UK Academy of Medical Sciences, Royal Society

Stefan Knapp, PhD,  Target Discovery Institute, Structuralb Genomics Consortium, University of Oxford

Mark Murcko, PhD,  Disruptive Biomedical, LLC;  Northeastern University;  Massachusetts Institute of Technology

Aviv Regev, PhD,  Massachusetts Institute of Technology, Broad Institute, Howard Hughes Medical Institute, Klarman Cell Observatory

Phillip Sharp, PhD,  Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Roger Tung, PhD,  Concert Pharmaceuticals

Chris Vakoc, MD, PhD,  Cold Spring Harbor Lab

Bob Weinberg, PhD,  Whitehead Institute, Massachusetts Institute of Technology, MIT Ludwig Center for Molecular Oncology
 

* Syros scientific founders